#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Deafness Proteus syndrome Gastrointestinal disorder Cutaneous calcification Intracranial germ cell tumour Progressive supranuclear palsy Candida infection Anti-HLA antibody test positive Familial dilated cardiomyopathy Bone marrow disorder Lupus nephritis Nodal marginal zone B-cell lymphoma Antiphospholipid syndrome Liver transplant rejection Autoimmune myositis More trials…

    Learn about Rare Diseases

    Ehlers-Danlos syndrome – Treatment Undifferentiated sarcoma Rhabdoid tumour – Life with Disease Gastrointestinal stromal tumour Medulloblastoma recurrent – Treatment Niemann-Pick disease Pleomorphic leiomyosarcoma – Diagnostics Mucopolysaccharidosis II – Diagnostics Rosai-Dorfman syndrome Mucopolysaccharidosis III – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    CHONDROITIN SULFATE SODIUM Ly3437943 Sodium SAROGLITAZAR HEMIMAGNESIUM Tipapkinogene Sovacivec GAXILOSE Mecillinam MZE829 Masitinib Gad20-209-Fsp-A4 DUVELISIB Clic-1901 Cart Zolbetuximab SRSD107 Eftilagimod Alfa Tinzaparin Regorafenib Quinidine Sulfate Vibosameran Roxadustat Mitapivat More therapies…

    Learn about Your Condition

    Brain stem glioma Thalassaemia beta Primary hyperthyroidism Large cell lung cancer Infantile spasms Immunodeficiency Glioma Endometrial stromal sarcoma Laryngeal cancer stage II Renal cancer Hyperparathyroidism secondary Endometrial cancer stage I Osteomyelitis H1N1 influenza Arthroscopy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Reproductive and Urinary Physiological Phenomena

  • Study on the Safety and Effectiveness of Apixaban and Warfarin for Patients with End-Stage Renal Disease on Peritoneal Dialysis and Atrial Fibrillation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Warfarin
    • Warfarin Sodium
    • Apixaban
    France

  • Study Comparing Corifollitropin Alfa and Modified Natural Cycles for Women with Subfertility and Low Ovarian Response

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility
    Investigated Drugs:
    • Corifollitropin Alfa
    • Ganirelix
    • Follitropin Beta
    Belgium

  • Study Comparing Corifollitropin Alfa and Progestin Primed Ovarian Stimulation for Women with Subfertility Undergoing Elective Fertility Preservation or Genetic Testing

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility
    Investigated Drugs:
    • Corifollitropin Alfa
    • Desogestrel
    • Ganirelix
    Belgium

  • Study on Random Start Ovarian Stimulation with Follitropin Alfa, Dydrogesterone, and Triptorelin Acetate for Women Undergoing Elective Oocyte Cryopreservation to Prevent Infertility

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility female
    Investigated Drugs:
    • Follitropin Alfa
    • Dydrogesterone
    • Triptorelin Acetate
    Belgium

  • Study on the Safety and Effectiveness of Platelet Concentrate for Women with Low Ovarian Reserve

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diminished ovarian reserve
    Investigated Drugs:
    • Platelet Concentrate
    Spain

  • Micronised progesterone luteal-phase support improves live birth rates in women with unexplained infertility

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Infertility
    • Infertility female
    Investigated Drugs:
    • Progesterone, Micronised
    The Netherlands
Previous Page
1 2 3 4 … 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!